1011 - 1020 of 6299 Results
Title
Year
- GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort2020OPENTitle: GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian CohortJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2106End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28195Best OA location URL: http://hdl.handle.net/11573/1433077Citation Count: 125
- A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy2020OPENTitle: A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System AtrophyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1957End Page: 1965Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28218Best OA location URL: https://doi.org/10.1002/mds.28218Citation Count: 73
- Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease2020OPENTitle: Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2028End Page: 2037Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28202Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28202Citation Count: 100
- Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease2020OPENTitle: Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1416End Page: 1427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28064Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28064Citation Count: 64
-
OPENTitle: Movement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 EraJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 911End Page: 911Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28094Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28094Citation Count: 39
-
OPENTitle: A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the NetherlandsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1667End Page: 1674Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28112Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28112Citation Count: 59
- Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations2020OPENTitle: Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and RecommendationsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 283End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28313Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28313Citation Count: 70
- Four‐Year Follow‐up of [18F]Fluorodeoxyglucose Positron Emission Tomography–Based Parkinson's Disease–Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression2020OPENTitle: Four‐Year Follow‐up of [18F]Fluorodeoxyglucose Positron Emission Tomography–Based Parkinson's Disease–Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 230End Page: 235Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28260Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28260Citation Count: 46
-
OPENTitle: Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase functionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-025-60134-4Best OA location URL: https://www.nature.com/articles/s41467-025-60134-4.pdfCitation Count: 0
- PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection2025OPENTitle: PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infectionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00945-wBest OA location URL: https://www.nature.com/articles/s41531-025-00945-w.pdfCitation Count: 1